Remedies or prophylactis for diseases in association with...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/445 (2006.01) A61K 31/40 (2006.01) A61P 19/00 (2006.01)

Patent

CA 2373942

Remedies or preventives for diseases in association with chemokines such as MIP-1.alpha. and/or MCP-1. Namely, remedies or preventives for diseases in association with chemokines (rheumatoid arthritis, nephritis, etc.) which contain as the active ingredient cyclic amine derivatives represented by general formula (I), pharmaceutically acceptable acid-adducts thereof, or pharmaceutically acceptable C1-6 alkyl-adducts thereof.

L'invention concerne des moyens de traitement et de prévention contre les maladies associées à des chimiokines, telles que MIP-1.alpha. et/ou MCP-1. A savoir, des moyens de traitement et de prévention contre les maladies associées à la chimiokine (polyarthrite rhumatoïde, néphropathie, etc.) contenant comme principe actif des dérivés cycliques d'amines correspondant à la formule générale (I), leurs adduits d'acide acceptables sur le plan pharmaceutique, leurs adduits d'alkyle C¿1-6? acceptables sur le plan pharmaceutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Remedies or prophylactis for diseases in association with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Remedies or prophylactis for diseases in association with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Remedies or prophylactis for diseases in association with... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1982362

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.